First rare transplant successfully completed in North Maharashtra HCG Manavata Cancer Care Hospital achieved yet another surgical milestone with a successful ‘half-matched’ Bone Marrow Transplant performed on a ten-year-old patient, suffering with Thalassemia. This is the first time such a rare transplant surgery was performed in
Prof. Dr. Raj Nagarkar, MD & Chief of Surgical Oncology and Robotic Services, HCG Manavata Cancer Centre, Nasik Kidneys form one of vital organs in the human body, the major contributors to our physical wellbeing. These bean-shaped organs, about the size of a fist, are located
The solar plant will generate 45 lakh units (3.265MWp) of clean electricity annually, offsetting 3300 tons of carbon emissions The 2.25MW solar installation is expected to reduce up to 70% of energy expenditure at two hospitals in Karnataka In an effort to conserve
In continuation of its endeavour to ensure world-class cancer care services and commitment towards cancer free society, HCG NCHRI Cancer centre Nagpur launched a unique campaign towards Transgender and other LGBT community by organising a one-day free cancer screening camp at the hospital campus, where
Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y) EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q) EBITDA for
Dr. Raj Nagarkar, a renowned oncologist and robotic surgeon from HCG Manavata Cancer Centre, Nasik becomes the world’s first surgeon to perform 702 robotic surgeries using the CMS Versius robotic technology in a short span of 35 months and 53 robotic surgeries in one month.
To provide patients access to world-class treatment facilities and with a commitment to offering high-quality clinical care, HCG Cancer Hospital, Bengaluru, one of India’s largest dedicated cancer care Hospitals announced the launch of India’s first Varian Ethos™ therapy, an Artificial Intelligence (AI)-driven holistic solution designed
HealthCare Global Enterprises Limited (HCG), the leading specialty healthcare service provider in India, focused on oncology, announced the acquisition of oncology hospital labs and clinical trials business from Strand Lifesciences as well as simultaneous divestment of its ~38.5% stake (on paid-up capital basis and 34.5%
